Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Oncology Pharma Inc. (ONPH : OTC)
 
 • Company Description   
Oncology Pharma Inc. is engaged in developing, manufacturing and commercializing therapeutics. The Company licensed Tulynode's patent pending Autologous Immuno-therapy for durable therapy response using an extracorporeal device. Oncology Pharma Inc., formerly knonw as SourcingLink.net Inc., is based in San Francisco, California.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.05 Daily Weekly Monthly
20 Day Moving Average: 223,769 shares
Shares Outstanding: 31.56 (millions)
Market Capitalization: $159.39 (millions)
Beta: -3.68
52 Week High: $50.00
52 Week Low: $0.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -46.73% -45.07%
12 Week -66.78% -67.11%
Year To Date 1,068.98% 707.33%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
16855 WEST BERNARDO DRIVE SUITE 260
-
SAN DIEGO,CA 92127
USA
ph: 858-385-8900
fax: 858-385-8997
None http://www.sourcinglink.net
 
 • General Corporate Information   
Officers
Marcel van Hee - Chairman of the Board of Directors
Michael Khoury - President
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 68235J201
SIC: 7372
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 31.56
Most Recent Split Date: 10.00 (0.01:1)
Beta: -3.68
Market Capitalization: $159.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/21 - -
06/30/21 - -
03/31/21 - -
ROA
09/30/21 - -
06/30/21 - -
03/31/21 - -
Current Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Quick Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - -
06/30/21 - -
03/31/21 - -
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Capital
09/30/21 - -
06/30/21 - -
03/31/21 - -
 

Powered by Zacks Investment Research ©